{"cardiac failure": 5.65, "condition aggravated": 3.93, "cyanosis": 6.27, "disease progression": 5.48, "drug interaction": 3.54, "fluid retention": 7.51, "general physical health deterioration": 3.72, "off label use": 2.34, "oxygen saturation decreased": 9.4, "product use in unapproved indication": 2.46, "product use issue": 5.69, "pulmonary arterial hypertension": 54.68, "pulmonary hypertension": 34.48, "pulmonary oedema": 9.37, "right ventricular failure": 94.4}